The Society of Cardiovascular Computed Tomography is cheering as a “huge win” the 2025 CMS payment increase for coronary CTA that more than doubles the current payment and “better aligns with the cost of providing CCTA services." The panel expects the move to bring an increase in CT utilization, more adoption with financial sustainability and greater access in currently underutilized areas.

Fazal Panezai, MD, faced up to 10 years in prison for coordinating a years-long fraud scheme from 2017 to 2022. His New Jersey medical license has already been permanently revoked.

Six multispecialty cardiovascular societies have called on CMS to approve Medicare payments for tricuspid transcatheter edge-to-edge repair (T-TEER).

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

Both FDA-approved systems previously received inpatient payments in August. 

Boston Scientific has scooped up Cortex, a healthcare technology company launched by the venture capital firm Ajax Health in 2023, in a move that will expand its EP offerings.

CMS continues to show confidence in the benefits of baroreflex activation therapy with the Barostim device from CVRx. 

The New Jersey doctor already admitted to collecting more than $1.9 million in false claims from 2017 to 2022. He is also under investigation for an unrelated charge of fourth-degree criminal sexual contact due to an alleged incident with a patient.